End-of-day quote
Shanghai S.E.
06:00:00 2024-07-01 pm EDT
|
5-day change
|
1st Jan Change
|
4.93
CNY
|
-1.60%
|
|
-1.40%
|
-9.28%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
26,006
|
33,241
|
26,919
|
24,052
|
26,691
|
24,215
|
-
|
-
|
Enterprise Value (EV)
1 |
28,388
|
36,125
|
29,021
|
21,882
|
24,319
|
21,406
|
21,714
|
20,600
|
P/E ratio
|
15.4
x
|
11.7
x
|
11.6
x
|
12.2
x
|
12.7
x
|
9.42
x
|
8.25
x
|
7.19
x
|
Yield
|
-
|
2.75%
|
2.04%
|
3.83%
|
3.57%
|
4.3%
|
4.82%
|
5.68%
|
Capitalization / Revenue
|
0.26
x
|
0.3
x
|
0.22
x
|
0.17
x
|
0.18
x
|
0.14
x
|
0.13
x
|
0.12
x
|
EV / Revenue
|
0.29
x
|
0.33
x
|
0.24
x
|
0.16
x
|
0.16
x
|
0.13
x
|
0.11
x
|
0.1
x
|
EV / EBITDA
|
10
x
|
7.36
x
|
6.93
x
|
6.21
x
|
6.5
x
|
3.85
x
|
3.57
x
|
2.92
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.42
x
|
1.75
x
|
1.31
x
|
1.09
x
|
1.14
x
|
1.02
x
|
0.92
x
|
0.89
x
|
Nbr of stocks (in thousands)
|
4,945,666
|
4,925,621
|
4,921,006
|
4,963,416
|
4,911,693
|
4,911,693
|
-
|
-
|
Reference price
2 |
5.258
|
6.749
|
5.470
|
4.846
|
5.434
|
4.930
|
4.930
|
4.930
|
Announcement Date
|
4/28/20
|
4/26/21
|
4/25/22
|
4/24/23
|
4/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
99,497
|
110,860
|
122,407
|
140,424
|
150,140
|
168,312
|
189,211
|
208,908
|
EBITDA
1 |
2,838
|
4,909
|
4,187
|
3,526
|
3,741
|
5,559
|
6,079
|
7,065
|
EBIT
1 |
2,301
|
4,352
|
3,593
|
2,853
|
3,023
|
4,033
|
4,554
|
5,672
|
Operating Margin
|
2.31%
|
3.93%
|
2.93%
|
2.03%
|
2.01%
|
2.4%
|
2.41%
|
2.71%
|
Earnings before Tax (EBT)
1 |
2,317
|
4,334
|
3,363
|
2,838
|
2,991
|
3,764
|
4,305
|
5,118
|
Net income
1 |
1,727
|
3,075
|
2,448
|
2,085
|
2,174
|
2,759
|
3,160
|
3,750
|
Net margin
|
1.74%
|
2.77%
|
2%
|
1.48%
|
1.45%
|
1.64%
|
1.67%
|
1.8%
|
EPS
2 |
0.3419
|
0.5760
|
0.4720
|
0.3976
|
0.4264
|
0.5234
|
0.5977
|
0.6858
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.1858
|
0.1115
|
0.1858
|
0.1938
|
0.2119
|
0.2374
|
0.2800
|
Announcement Date
|
4/28/20
|
4/26/21
|
4/25/22
|
4/24/23
|
4/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
35,776
|
40,472
|
40,389
|
43,755
|
43,671
|
37,515
|
45,018
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,346
|
1,444
|
1,544
|
1,330
|
1,552
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
614.6
|
665.4
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.72%
|
1.64%
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
618.7
|
661.8
|
978
|
1,059
|
1,376
|
937.1
|
1,124
|
Net income
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
350.4
|
537.7
|
744.3
|
806.3
|
1,013
|
713.1
|
855.8
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.98%
|
1.33%
|
1.84%
|
1.84%
|
2.32%
|
1.9%
|
1.9%
|
EPS
2 |
0.0149
|
0.0855
|
0.1598
|
0.0892
|
0.0632
|
0.1078
|
0.1550
|
-
|
0.1085
|
0.1588
|
0.1550
|
0.1754
|
0.1414
|
0.1697
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/25/22
|
4/25/22
|
8/22/22
|
10/24/22
|
4/24/23
|
4/24/23
|
8/28/23
|
4/26/24
|
4/26/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
2,381
|
2,884
|
2,102
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
2,170
|
2,372
|
2,809
|
2,500
|
3,615
|
Leverage (Debt/EBITDA)
|
0.8391
x
|
0.5876
x
|
0.5021
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
9.32%
|
15.9%
|
11.4%
|
8.98%
|
9.04%
|
10.8%
|
11.4%
|
12.7%
|
ROA (Net income/ Total Assets)
|
2.51%
|
4.05%
|
2.94%
|
2.34%
|
2.35%
|
2.6%
|
2.75%
|
-
|
Assets
1 |
68,924
|
75,984
|
83,379
|
89,104
|
92,552
|
106,129
|
114,912
|
-
|
Book Value Per Share
2 |
3.710
|
3.850
|
4.160
|
4.450
|
4.760
|
4.830
|
5.350
|
5.520
|
Cash Flow per Share
2 |
0.5500
|
0.6800
|
0.6900
|
0.7900
|
0.9400
|
-1.670
|
1.070
|
-0.0800
|
Capex
1 |
1,175
|
1,158
|
1,215
|
1,083
|
885
|
1,165
|
1,201
|
1,468
|
Capex / Sales
|
1.18%
|
1.04%
|
0.99%
|
0.77%
|
0.59%
|
0.69%
|
0.63%
|
0.7%
|
Announcement Date
|
4/28/20
|
4/26/21
|
4/25/22
|
4/24/23
|
4/26/24
|
-
|
-
|
-
|
Last Close Price
4.93
CNY Average target price
7.856
CNY Spread / Average Target +59.35% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.28% | 3.39B | | +26.32% | 76.05B | | -4.23% | 23.81B | | +15.24% | 8.8B | | +1.71% | 8.29B | | -33.21% | 6.77B | | +19.66% | 5.36B | | +0.89% | 4.06B | | -8.73% | 3.77B | | +8.56% | 3.28B |
Pharmaceuticals Wholesale
|